REFERENCES
1. Celli BR, MacNee W. Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper. The European Respiratory Journal. 2004; 23(6): 932-946. doi: 10.1183/09031936.04.00014304
2. Garvey C. Recent updates in chronic obstructive pulmonary disease. Postgraduate Medicine. 2015; 1-10. doi: 10.1080/0032 5481.2016.1118352
3. Vestbo J, Hurd SS, Agusti AG, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. American Journal of Respiratory and Critical Care Medicine. 2013; 187(4): 347-365. doi: 10.1164/rccm.201204-0596PP
4. Barnes PJ. Chronic obstructive pulmonary disease: effects beyond the lungs. PLoS Medicine. 2010; 7(3): e1000220. doi: 10.1371/ journal.pmed.1000220
5. Gan WQ, Man SFP, Senthilselvan A, Sin DD. Association between chronic obstructive pulmonary disease and systemic inflammation: a systematic review and a meta-analysis. Thorax. 2004; 59(7): 574-580. doi: 10.1136/thx.2003.019588
6. Pelaia G, Vatrella A, Busceti MT, et al. Pharmacologic rationale underlying the therapeutic effects of tiotropium/olodaterol in COPD. Ther Clin Risk Manag. 2015; 11: 1563-1572. doi: 10.2147/TCRM.S84151
7. Pelaia G, Terracciano R, Vatrella A, et al. Application of proteomics and peptidomics to COPD. BioMed Research International. 2014; 2014: 764581. doi: 10.1155/2014/764581
8. Watt J, Ganapathi P. COPD: Novel therapeutics and management strategies–SMi’s 7th Annual Conference (October 19-20, 2015–London, UK). Drugs Today (Barc). 2015; 51(10): 613-617. doi: 10.1358/dot.2015.51.10.2409817
9. Pelaia G, Vatrella A, Gallelli L, et al. Biological targets for therapeutic interventions in COPD: clinical potential. International Journal of Chronic Obstructive pulmonary disease. 2006; 1(3): 321-334.
10. Sarioglu N, Hismiogullari AA, Bilen C, Erel F. Is the COPD assessment test (CAT) effective in demonstrating the systemic inflammation and other components in COPD? Revista Portuguesa De Pneumologia. 2015.
11. Anderson P. Post-transcriptional regulons coordinate the initiation and resolution of inflammation. Nature Reviews Immunology. 2010; 10(1): 24-35. doi: 10.1038/nri2685
12. O’Connell RM, Rao DS, Baltimore D. microRNA regulation of inflammatory responses. Annual Review of Immunology. 2012; 30: 295-312. doi: 10.1146/annurev-immunol-020711-075013
13. Jiang X, Tsitsiou E, Herrick SE, Lindsay MA. MicroRNAs and the regulation of fibrosis. The FEBS Journal. 2010; 277(9): 2015- 2021. doi: 10.1111/j.1742-4658.2010.07632.x
14. Ramachandran S, Karp PH, Osterhaus SR, et al. Post-transcriptional regulation of cystic fibrosis transmembrane conductance regulator expression and function by microRNAs. American Journal of Respiratory Cell and Molecular Biology. 2013; 49(4): 544- 551. doi: 10.1165/rcmb.2012-0430OC
15. Stolzenburg LR, Wachtel S, Dang H, Harris A. microRNA-1343 attenuates pathways of fibrosis by targeting the TGF-beta receptors. The Biochemical Journal. 2015. doi: 10.1042/BJ20150821